MedPath

Burden in quality of life (QOL), work productivity and healthcare cost for caregivers of patients with schizophrenia, depression, Alzheimer's disease, dementia and stroke

Not Applicable
Conditions
caregivers of patients with schizophrenia, depression, Alzheimer&#39
s disease, dementia and stroke
Registration Number
JPRN-UMIN000049038
Lead Sponsor
Otsuka Pharmaceutical Co., Ltd. Medical Affairs Department
Brief Summary

The result showed that all caregiver groups had significantly higher CCI than non-caregivers. Caregivers of depression were younger, and a larger proportion of them were currently employed.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
50117
Inclusion Criteria

Not provided

Exclusion Criteria

- Respondents who did not provide sufficient answers are excluded from the study. - For respondents who participated in both NHWS 2016 and 2018, only the most recent response (NHWS 2018) will be collected and the response from NHWS 2016 will be excluded.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath